Hirsch Douglas Joseph has made a notable move by acquiring 20,521 shares of GoodRx Holdings, Inc. on October 26, 2026. This transaction is significant as it underscores the ongoing commitment of insiders to the company, which operates in the services sector focused on computer processing and data preparation.
GoodRx Holdings, Inc. is a prominent player in the healthcare technology space, providing tools and resources to help consumers navigate prescription drug pricing. The company is listed under the ticker symbol GDRX and operates from Santa Monica, California.
According to the recent SEC filing (accession number 0001809519-26-000179), Hirsch's transaction involved acquiring shares of Class A Common Stock. Following this acquisition, he now holds a total of 341,457 shares directly. The filing states, "Transaction Code: M" indicating a purchase, and it specifies that the shares were acquired on the same date as the transaction.
This acquisition may impact various stakeholders, including shareholders and potential investors. Insider transactions like this can signal confidence in the company's future, potentially influencing market sentiment.
Looking ahead, the filing does not specify what actions will follow this transaction, leaving the next steps unclear for observers.
In addition to the acquisition of shares, the SEC filing reveals that Hirsch Douglas Joseph also holds shares through various grantor retained annuity trusts (GRATs). Specifically, he has ownership interests in shares held by the DH 2024-2 GRAT and DH 2025 GRAT, where he serves as the sole trustee and annuitant. These trusts hold a total of 543,377 shares and 2,089,343 shares of Class A Common Stock, respectively.
Furthermore, the filing indicates that Hirsch's spouse, Chona Hirsch, manages additional shares through the CH 2024-2 GRAT and CH 2025 GRAT, which he does not have a pecuniary interest in or control over. This structure highlights a strategic approach to asset management within family trusts.
The transaction also included the acquisition of 20,521 restricted stock units (RSUs), which are contingent rights to receive shares of Class A Common Stock. These RSUs are set to vest over a three-year period, beginning on October 26, 2025, subject to continued service. This vesting schedule aligns with typical compensation structures aimed at retaining key personnel.
Overall, the filing provides a detailed view of Hirsch's significant holdings in GoodRx Holdings, Inc., emphasizing both his direct ownership and the complexity of his investment strategy through family trusts.